Please Wait...

Clinical IVR/IWR

Drug Supply Shortages in Clinical Trials, Part 3

  • 0
  • 15 Aug

Final installment in a three-part series on drug supply shortages in clinical trials with BioClinica's Trident IRT Team.

If you've been following this blog series on drug shortages, you know why it's so important to stay on top of clinical trial drug supply and the potential impact on clinical trials when shortages do occur: subject loss, lowered enrollment, budget escalation, delays and even study discontinuation.

Read More

Drug Supply Shortages in Clinical Trials, Part 2

  • 0
  • 11 Aug
In this blog, we'll see where drug shortages create impacts and what some of the most common root causes are. Coming soon in Part 3 in this series, I'll share some real-life examples of trials where BioClinica was called into rescue mode. So stay tuned and you may pick up some tips to steer clear of drug shortages in your own program.
Read More

Drug Supply Shortages in Clinical Trials, Part 1

  • 0
  • 05 Aug

John Burns, a member of BioClinica's Trident IRT team, was asked to present on drug shortages in clinical trials as part of a panel discussion at DIA. In it, he outlined examples of preventable causes and shared case studies showing what happens when things go awry.  Here is Part 1 in a three-part blog series recapping his discussion.

Read More

With IRT Becoming the Gold Standard, Do We Still Need IVR?

  • 0
  • 29 Oct

With the advanced functionality and mobile accessibility of web-based Interactive Response Technology (IRT), is Interactive Voice Response (IVR) still needed?

The reality is, BioClinica continues to receive RFPs with the phone component included — but afterward the IVR goes unused. So I question how much longer customers will request it and for how much longer IVR will be maintained alongside IRT. Is the voice system there to serve as a back-up, for comfort, or is it for some other reason?

Read More
Electronic data capture in clinical trials tips

Electronic Data Capture in Clinical Trials and IVR Study Setup Tips

  • 0
  • 29 Jan

While they offer sponsors the ability to run faster, more efficient clinical trials, using an Electronic Data Capture (EDC) or an Interactive Voice/Web Response (IVR/IWR) system can be a challenge for any sponsor. Large pharma, small biotechs, CROs, device companies, and academic research centers all go through the same study startup process of determining which data needs to be collected, and how to assure the data is correct and complete.

Read More

Selecting the Right IVR IWR System for Your Clinical Trials

  • 0
  • 01 Feb

With all of the decisions surrounding the launch of a clinical trial, choosing an IVR system to support your study can be a daunting task. Here are just a few of the things that you should look for when choosing an IVR/IWR system for your clinical trial organization.

  • Study build time
  • Ability to make last minute changes
  • Ability to support custom complex protocols
Read More

Modeling IVR Studies Ship Times

  • 0
  • 18 Aug
We often run into cases where an IVR (interactive voice response) system may not generate shipment orders for study kits every day. For example, commonly it seems they may only ship Monday through Thursday. In many cases this could be due to cold chain supplies having to be received immediately and being unable to guarantee that someone will be there to receive the shipment on a weekend. Others, however, may be for unrelated policy reasons. Standard modeling practice says to add a day to the shipping lead-time for every day that is not available for shipping (3 days in the case of the above example). Related to this concept, there is often some confusion for new users about whether the shipping lead-time for the IVR study refers to calendar days or business days.
Read More

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Bioclinica is organized into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging & Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Molecular Marker Laboratory. Our eHealth segment comprises eClinical Solutions, Randomization & Trial Supply Management, Safety & Regulatory Solutions, and Financial Lifecycle Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

RT @eClinical_Jen: FREE on-demand webinars from @bioclinica on EDC, Imaging, RBM, and Clinical Trial Management. Tell them I sent you! http…
bioclinica (11 hours ago)
Excited to host NJ Lt. Gov. Kim Guadagno, clients, partners 9/28 in Princeton! In the area? Join us ! RSVP… https://t.co/PrfyxvasGb
bioclinica (Yesterday)
Be sure to follow #ThankAScientist all week to thank researchers for the work they do! https://t.co/Sfi9mmHbSk… https://t.co/y9ZhBXsIzu
bioclinica (2 days ago)
Cardiovascular imaging use is growing in non-cardiovascular areas #ClinicalTrials. See where in Tim Crowe's blog… https://t.co/dYjPBC0Wtn
bioclinica (2 days ago)
RT @Xtalks: Cardiovascular Safety in #Biopharmaceutical Product Development - From QT Prolongation and Beyond @bioclinica https://t.co/mCk1…
bioclinica (2 days ago)
RT @Xtalks: How Innovations in Data Visualization Are Accelerating Data Cleaning and Improving Quality @bioclinica https://t.co/vfLU8pS9Rd
bioclinica (2 days ago)

Latest Blogs: